DescriptionHigh-performance computing has long been employed in
cancer research and clinical applications. Ongoing
challenges of deriving insight from increasing amounts
of cancer related information have accelerated the
significance of HPC and collaborations in cancer
research, in areas including simulations, data analytics
and deep learning. Underscored by several recent
high-profile efforts, communities are rapidly developing
where HPC is applied to cancer challenges. This SC17 BoF
provides an important venue, bringing these communities
together around a common theme of HPC and cancer.
Following the successful format of past years, the BoF
will be informative and highly-interactive with
presentations and significant attendee discussion.